Oxford Health NHS Foundation Trust would like  to congratulate Professor Vanessa Raymont, the Trust’s R&D Director, on her appointment as Director of Dementias Platform UK (DPUK), one of the UK’s leading dementia research organisations.

A clinician, researcher and previous associate director within DPUK, Professor Raymont has played a key role in advancing dementia research across the UK. She leads DPUK’s Trials Delivery Framework (TDF)and co-leads the READ-OUT study, a major national initiative exploring the use of blood biomarkers to improve the diagnosis of dementia and cognitive impairment that is running across TDF sites.

Professor Raymont takes on this role at an exciting time for dementia research, with increasing opportunities to improve diagnosis, accelerate access to new treatments and strengthen participation in research. She succeeds Professor John Gallacher, who is stepping down after more than a decade leading the organisation.

Throughout her career, Professor Raymont has combined clinical expertise with a commitment to advancing research that improves understanding, diagnosis and care for people affected by dementia. At Oxford Health, she has been instrumental in developing and supporting a wide range of dementia studies, helping to strengthen the Trust’s contribution to national and international research efforts.

Professor Vanessa Raymont

She told us, “These are exciting times for dementia research. With advances in biomarkers, diagnostics and emerging treatments, we have a real opportunity to transform the way we detect and manage dementia. I am looking forward to working with colleagues across DPUK and beyond to help drive that progress.”

Her appointment reflects the growing influence of Oxford-led dementia research on the national stage.

Everyone at Oxford Health would like to congratulate Professor Raymont on this well-deserved achievement and wish her every success as she leads DPUK into its next chapter.